Pharmaceuticals - Community Register


List of nationally authorised medicinal products for human use


Product name: Cilostazol
Also marketed in the EU under the name(s): EKISTOL, PLETAL
Active substance: cilostazol
Indication: Cilostazol is indicated for the improvement of the maximal and pain-free walking distances in patients with intermittent claudication, who do not have rest pain and who do not have evidence of peripheral tissue necrosis (peripheral arterial disease Fontaine stage II).
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/06/2013 Referral EMEA/H/A-31/1306 (2013)4095 of 24/06/2013